18th annual Tekne Awards recognized Minnesota’s technology innovators and innovations
2017 Tekne Awards
Minneapolis, MN, 15 November 2017 — The Minnesota High Tech Association (MHTA) has named StemoniX, Inc. as the recipient of the 2017 Tekne Award in the Start Up award category. Held November 15 at the Minneapolis Convention Center, the Tekne Awards honor companies and individuals who have played a significant role in developing new technologies that positively impact the lives and futures of people living around the world.
StemoniX transforms human induced Pluripotent Stem Cells (iPSC) into functioning microHeart® and microBrain® platforms for disease modeling and drug discovery and development. Their innovative technology allows medicines to be tested and perfected on individual human tissues before actual testing in humans. StemoniX is currently involved in partnerships with several organizations including Pairnomix™ to model epilepsy and the US military to study viral infections.
“Our microBrain and microHeart platforms are changing how medicines are developed so that they are safer for everyone,” said Ping Yeh, the CEO and founder of StemoniX. “We are proud to have our technology chosen from among such prestigious organizations and are excited to be recognized as leaders in Minnesota’s innovation community.”
Tekne Awards were presented to 13 of Minnesota’s most influential companies and recognized innovations and promising futures in software, healthcare, STEM education, Start Up, workforce development, cyber security, and more.
“Minnesota continues to be a national leader in technology and science, and this year’s Tekne Award recipients are clear evidence of that,” said Margaret Anderson Kelliher, president and CEO of MHTA. We are honored to recognize StemoniX for their innovations and achievements.”
This year’s Tekne Awards ceremony was emceed by meteorologist and entrepreneur Paul Douglas. A list of 2017 Tekne Award recipients and finalists is available online at http://www.tekneawards.org.
StemoniX® is transforming how medicine is discovered. By using skin or blood to create functioning microHearts® and microBrains®, StemoniX is making it possible to test medication on humans without that medication ever entering their bodies. This method of drug testing will speed up the search for new cures and enable the ability to test drug effectiveness on an individual person, so medicine works correctly the first time. For more information visit www.stemonix.com.
About Minnesota High Tech Association (MHTA)
MHTA is an innovation and technology association united in fueling Minnesota’s prosperity. We help bring together the people of Minnesota’s technology ecosystem and lead the charge in directing technology issues to Minnesota’s state capitol. MHTA is the only membership organization that represents Minnesota’s entire technology-based economy. MHTA members include organizations of every size − involved in virtually every aspect of technology creation, production, application and education in Minnesota. Find out more online at http://www.mhta.org or follow MHTA on Twitter at http://twitter.com/MHTA.